Thermal inactivation of protective antigen of Bacillus anthracis and its prevention by polyol osmolytes.
Protective antigen (PA) of Bacillus anthracis is the main immunogen of all anthrax vaccines. It is a highly thermolabile molecule and loses its activity rapidly when exposed to higher temperatures. Earlier some cosolvents had been used to stabilize PA with variable success but no study has been done to find out the primary cause of PA thermal inactivation. This study aims at elucidating the predominant cause of thermal inactivation of PA in order to develop more effective strategies for its thermostabilization. The prime cause for the loss of biological activity of PA at high temperature was its aggregation and an inverse correlation between PA activity and its aggregation on heating was observed. Inactivation of the protein by autolysis did not occur. This paper reports the use of a series of polyol osmolytes to stabilize PA. Different polyols stabilized PA to a different extent against thermal inactivation in a concentration dependent manner, with glycerol stabilizing to the maximum extent. Addition of NaCl to glycerol solution further enhanced the thermal stability of PA. An increase in the T(1/2) value, the temperature at which 50% of the activity is retained during short-term incubation, of more than 20 degrees C was observed. The half-life (t(1/2)) of PA thermal inactivation at 40 degrees C increased by more than 6 times in the presence of the mixture of glycerol and NaCl as compared to control. This study demonstrates for the first time that aggregation of the PA molecule is the predominant cause of its thermal inactivation, and can be very effectively prevented by the use of glycerol and other polyols to increase the shelf life of the recombinant vaccine against anthrax.
Singh
Samer
S
Centre for Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India.
Singh
Aparna
A
Aziz
Mohd Azhar
MA
Waheed
Syed Mohsin
SM
Bhat
Rajiv
R
Bhatnagar
Rakesh
R
D000818:Animals; D022122:Anthrax Vaccines / Q000276:immunology; D000942:Antigens, Bacterial / Q000737:chemistry*; D001329:Autolysis; D001408:Bacillus anthracis / Q000276:immunology*; D002460:Cell Line; D004926:Escherichia coli / Q000235:genetics; D017737:Macrophages, Peritoneal / Q000276:immunology; D051379:Mice; D011108:Polymers / Q000494:pharmacology*; D013816:Thermodynamics
D022122:Anthrax Vaccines; D000942:Antigens, Bacterial; D011108:Polymers; C024617:polyol